|
|
Blood, 15 May 2005, Vol. 105, No. 10, pp. 3786-3792.
Prepublished online as a Blood First Edition Paper on January 27, 2005; DOI 10.1182/blood-2004-10-4125.
 Previous Article | Table of Contents | Next Article 
REVIEW IN TRANSLATIONAL HEMATOLOGY
New trends in umbilical cord blood transplantation
Karen K. Ballen
From Massachusetts General Hospital, Boston, MA.
Abstract
Since the first report of a successful umbilical cord blood transplantation in 1988, there has been great interest in the use of cord blood as an alternative stem cell source to treat cancer and genetic diseases. More than 4000 cord blood transplantations have been performed worldwide. In this review, the scientific rationale for this therapy, as well as related preclinical studies, cord blood banking issues, and ethical concerns, will be addressed. Results of studies in both pediatric and adult transplantation will be discussed. Finally, new indications for cord blood use and emerging technologies will be addressed.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Smythe, S. Armitage, D. McDonald, D. Pamphilon, M. Guttridge, J. Brown, A. Green, C. Brown, R. M. Warwick, A. Lankester, et al.
Directed Sibling Cord Blood Banking for Transplantation: The 10-Year Experience in the National Blood Service in England
Stem Cells,
August 1, 2007;
25(8):
2087 - 2093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Lin, S. W. Y. Cheung, M. Nesin, B. R. Cassileth, and S. Cunningham-Rundles
Enhancement of Umbilical Cord Blood Cell Hematopoiesis by Maitake Beta-Glucan Is Mediated by Granulocyte Colony-Stimulating Factor Production
Clin. Vaccine Immunol.,
January 1, 2007;
14(1):
21 - 27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Aschan
Allogeneic haematopoietic stem cell transplantation: current status and future outlook
Br. Med. Bull.,
October 5, 2006;
(2006)
ldl005v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Noronha, N. Berliner, K. K. Ballen, J. Lacy, J. Kracher, J. Baehring, and J. W. Henson
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature
Neuro-oncol,
July 1, 2006;
8(3):
280 - 283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Nevessignsky and A. Ferster
Haematopoietic stem cell transplantation for severe autoimmune diseases: new perspectives
Nephrol. Dial. Transplant.,
May 1, 2006;
21(5):
1154 - 1157.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Serrano, T. Pfeiffer, S. Olivares, T. Numbenjapon, J. Bennitt, D. Kim, D. Smith, G. McNamara, Z. Al-Kadhimi, J. Rosenthal, et al.
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy
Blood,
April 1, 2006;
107(7):
2643 - 2652.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
